285 related articles for article (PubMed ID: 25769971)
1. Drug design for neglected disease in Brazil.
Giarolla J; Ferreira EI
Mini Rev Med Chem; 2015; 15(3):220-42. PubMed ID: 25769971
[TBL] [Abstract][Full Text] [Related]
2. Potential Triazole-based Molecules for the Treatment of Neglected Diseases.
Mantoani SP; de Andrade P; Chierrito TPC; Figueredo AS; Carvalho I
Curr Med Chem; 2019; 26(23):4403-4434. PubMed ID: 28748757
[TBL] [Abstract][Full Text] [Related]
3. Heterocyclic N-oxides - A Promising Class of Agents against Tuberculosis, Malaria and Neglected Tropical Diseases.
Dos Santos Fernandes GF; Pavan AR; Dos Santos JL
Curr Pharm Des; 2018; 24(12):1325-1340. PubMed ID: 29663875
[TBL] [Abstract][Full Text] [Related]
4. Natural Products as a Source for Antileishmanial and Antitrypanosomal Agents.
Scotti MT; Scotti L; Ishiki H; Ribeiro FF; Cruz RM; Oliveira MP; Mendonça FJ
Comb Chem High Throughput Screen; 2016; 19(7):537-53. PubMed ID: 27682867
[TBL] [Abstract][Full Text] [Related]
5. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue.
Boniface PK; Ferreira EI
Phytother Res; 2019 Oct; 33(10):2473-2517. PubMed ID: 31441148
[TBL] [Abstract][Full Text] [Related]
6. Hybrid Molecules: Promising Compounds for the Development of New Treatments Against Leishmaniasis and Chagas Disease.
Cardona-G W; Yepes AF; Herrera-R A
Curr Med Chem; 2018; 25(30):3637-3679. PubMed ID: 29521209
[TBL] [Abstract][Full Text] [Related]
7. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
[TBL] [Abstract][Full Text] [Related]
8. Computer-Aided Drug Design Using Sesquiterpene Lactones as Sources of New Structures with Potential Activity against Infectious Neglected Diseases.
Herrera Acevedo C; Scotti L; Feitosa Alves M; Formiga Melo Diniz MF; Scotti MT
Molecules; 2017 Jan; 22(1):. PubMed ID: 28054952
[TBL] [Abstract][Full Text] [Related]
9. Infectious diseases. Overcoming neglect of kinetoplastid diseases.
Bilbe G
Science; 2015 May; 348(6238):974-6. PubMed ID: 26023124
[No Abstract] [Full Text] [Related]
10. Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis.
Njogu PM; Guantai EM; Pavadai E; Chibale K
ACS Infect Dis; 2016 Jan; 2(1):8-31. PubMed ID: 27622945
[TBL] [Abstract][Full Text] [Related]
11. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
12. Privileged small molecules against neglected tropical diseases: A perspective from structure activity relationships.
Abbasi Shiran J; Kaboudin B; Panahi N; Razzaghi-Asl N
Eur J Med Chem; 2024 May; 271():116396. PubMed ID: 38643671
[TBL] [Abstract][Full Text] [Related]
13. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
[TBL] [Abstract][Full Text] [Related]
14. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I.
Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
Curr Med Chem; 2012; 19(14):2128-75. PubMed ID: 22414103
[TBL] [Abstract][Full Text] [Related]
15. Current prospects of synthetic curcumin analogs and chalcone derivatives against mycobacterium tuberculosis.
Bukhari SN; Franzblau SG; Jantan I; Jasamai M
Med Chem; 2013 Nov; 9(7):897-903. PubMed ID: 23305394
[TBL] [Abstract][Full Text] [Related]
16. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
[TBL] [Abstract][Full Text] [Related]
17. Search for Antiprotozoal Activity in Herbal Medicinal Preparations; New Natural Leads against Neglected Tropical Diseases.
Llurba Montesino N; Kaiser M; Brun R; Schmidt TJ
Molecules; 2015 Aug; 20(8):14118-38. PubMed ID: 26248069
[TBL] [Abstract][Full Text] [Related]
18. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
19. Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review.
Santos SS; de Araújo RV; Giarolla J; Seoud OE; Ferreira EI
Int J Antimicrob Agents; 2020 Apr; 55(4):105906. PubMed ID: 31987883
[TBL] [Abstract][Full Text] [Related]
20. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
